Gene therapy for therapeutic myocardial angiogenesis: A promising synthesis of two emerging technologies
- 1 June 1998
- journal article
- review article
- Published by Springer Nature in Nature Medicine
- Vol. 4 (6) , 739-742
- https://doi.org/10.1038/nm0698-739
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Induction of Neoangiogenesis in Ischemic Myocardium by Human Growth FactorsCirculation, 1998
- Results of Intracoronary Recombinant Human Vascular Endothelial Growth Factor (rhVEGF) Administration TrialJournal of the American College of Cardiology, 1998
- Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic AngiogenesisPublished by Elsevier ,1996
- Intracoronary gene transfer of fibroblast growth factor–5 increases blood flow and contractile function in an ischemic region of the heartNature Medicine, 1996
- Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide.Journal of Clinical Investigation, 1995
- Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factorJournal of Vascular Surgery, 1995
- Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.Circulation, 1994
- The Histopathology of Kidney Changes in Rats and Monkeys Following Intravenous Administration of Massive Doses of FCE 26184, Human Basic Fibroblast Growth FactorToxicologic Pathology, 1993
- The fibroblast growth factor family: Structural and biological propertiesProgress in Growth Factor Research, 1989
- Transplacental Carcinogenesis by StilbestrolNew England Journal of Medicine, 1971